Dyadic International, Inc.

Company Listings from SPi: Dyadic International, Inc.

You are here: Home >> SPi Company Listings >> Dyadic International, Inc.

Patented technologies to discover, develop, manufacture and sell enzymes and other proteins for bioenergy, bio-based chemical, biopharmaceutical and industrial

 

Dyadic International, Inc.

Investor Relations: Dyadic International, Inc., Michael Faby, Chief Financial Officer, Phone: 561-743-8333, Email: mfaby@dyadic.com

Website:
http://www.dyadic.com

Search for other references to "dyadic" on SPi News

Latest Dyadic International, Inc. News

Dyadic International Announces Research Collaboration with Sanofi-Aventis JUPITER, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applyin...... 16:18 GMT Friday 7th September 2018

Dyadic International Reports Second Quarter 2018 Financial Results and Extension of Stock Repurchase Program JUPITER, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying...... 21:00 GMT Thursday 9th August 2018

Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018 JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Thursday 26th July 2018

Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics JUPITER, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 14:50 GMT Monday 18th June 2018

Dyadic International Reports First Quarter 2018 Financial Results JUPITER, Fla., May 10, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying i...... 21:30 GMT Thursday 10th May 2018

Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018 JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Wednesday 25th April 2018

Dyadic International Announces 2017 Year End Results and Recent Developments JUPITER, Fla., March 27, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 21:30 GMT Tuesday 27th March 2018

Dyadic International Appoints Chief Accounting Officer JUPITER, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), today announced that Chief Financial Officer Thomas L. Dubinski
 will...... 20:30 GMT Thursday 15th March 2018

Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018 JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 20:30 GMT Tuesday 13th March 2018

Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To Produce Two Target Proteins in C1 JUPITER, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying...... 13:30 GMT Tuesday 27th February 2018

Buy Dyadic International, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us